Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
Philip Dunn said bins would make it easier for men who had incontinence, as a side effect of prostate cancer treatment, to dispose of hygiene products. It is the most common cancer in men and ...
NEW YORK, NY, UNITED STATES, December 26, 2024 /EINPresswire / -- The Founding of CARER – A Vision of Comfort and Dignit ...
The Red Devils will provide designated bins and products such as pads ... are asking organisations to implement to support men with incontinence. One in eight men will get prostate cancer ...